Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The evidence for the critical clinical repercussions stemming from the simultaneous, dys-regulated expression of multiple
components within both the pro-inflammatory and chemoresistance pathways is evermore present within a large
spectrum of cancer conditions. The author?s team is currently investigating the level of dys-regulated gene expression of
hallmark pro-inflammatory genes within multiple, validated chemoresistanttumour cell line models such as neuroblastoma,
breast and prostate carcinomas.In essence, identification of these novel interplays can demonstrate to contribute key diagnostic
and prognostic biomarkers that can serve the oncology clinician to take more informed clinical decisions, based on the
individual tumour characteristics. Such informed clinical decisions ultimately allow for bespoke and enhanced therapeutic
efficacy, possibly utilising current anti-inflammatory drug treatments, with minimal suffering to the individual cancer patient
presenting with chemoresistanttumours.
Biography
Duncan Ayers has completed his PhD in Translational Medicine from The University of Manchester (UK) and is currently continuing his postdoctoral studies at The
University of Malta. He is also a Research Associate with the Faculty of Medicine & Human Health Sciences at the University of Manchester. During his doctoral
studies, he also spent a 17-month attachment with the Vandesompele group at the Center for Medical Genetics Ghent (Ghent University, Ghent, Belgium). He has
published/presented his research in more than 34 reputed journal papers and international meetings, together with contributing to four book publications
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals